SG Americas Securities LLC Cuts Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

SG Americas Securities LLC reduced its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 79.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,260 shares of the company’s stock after selling 88,606 shares during the period. SG Americas Securities LLC’s holdings in Acadia Healthcare were worth $675,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in ACHC. Treasurer of the State of North Carolina grew its position in Acadia Healthcare by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock worth $1,586,000 after acquiring an additional 250 shares during the period. Coldstream Capital Management Inc. increased its holdings in shares of Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock valued at $257,000 after acquiring an additional 303 shares during the period. Covestor Ltd increased its stake in Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after buying an additional 310 shares during the period. Xponance Inc. raised its position in Acadia Healthcare by 5.9% during the 4th quarter. Xponance Inc. now owns 10,530 shares of the company’s stock worth $418,000 after buying an additional 590 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. raised its position in Acadia Healthcare by 3.4% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 19,529 shares of the company’s stock worth $774,000 after buying an additional 634 shares during the last quarter.

Acadia Healthcare Price Performance

ACHC opened at $21.56 on Friday. The company has a fifty day simple moving average of $23.13 and a 200 day simple moving average of $32.47. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of 10.62, a PEG ratio of 4.03 and a beta of 0.94. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The company had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. During the same period last year, the business earned $0.84 EPS. The firm’s revenue for the quarter was up .3% compared to the same quarter last year. Equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on ACHC shares. Bank of America lowered their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Wall Street Zen upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Thursday, May 22nd. Guggenheim assumed coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price objective for the company. Stephens raised shares of Acadia Healthcare to a “hold” rating in a research report on Monday, June 2nd. Finally, Mizuho dropped their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating for the company in a research report on Wednesday, May 14th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.